Uniformed Services University of the Health Sciences   Report issue

Government Phase 2 Phase 3 Phase 4
Founded: Bethesda MD United States (1972)

Organization Overview

First Clinical Trial
2001
NCT00841399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences | Uniformed Services University of the Health Sciences | Uniformed Services Univ of the Health Sciences

Active Ingredients

Drugs in Phase 4 Trials (5)

inactivated influenza vaccine (2 trials)

lidocaine (xylocaine) (1 trial)

live attenuated influenza virus vaccine (flumist) (1 trial)

protein rich plasma (1 trial)

triamcinolone (kenalog) (2 trials)

Drugs in Phase 3 Trials (4)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

bcg tice (1 trial)

bcg (tokyo 172) vaccine (1 trial)

pneumococcal 7-valent conjugate vaccine (prevnar) (1 trial)

Drugs in Phase 2 Trials (18)

abobotulinumtoxinA (Dysport) (1 trial)

acetylcysteine (mucomyst) (1 trial)

bivalent rluks-pv / rat (1 trial)

carbon dioxide (dry ice) (1 trial)

cetuximab (erbitux) (1 trial)

cisplatin (platinol) (1 trial)

e75 + gm-csf vaccine (2 trials)

epoetin (Epogen) (1 trial)

erenumab (aimovig) (1 trial)

gadolinium (1 trial)

gentamicin (garamycin) (1 trial)

methylphenidate (ritalin) (1 trial)

ndv-3 (1 trial)

paromomycin (humatin) (2 trials)

riluzole (rilutek) (1 trial)

sildenafil (viagra) (2 trials)

sodium stibogluconate (1 trial)

staphylococcus aureus toxoids (1 trial)

Drugs in Other Trials (19)

azithromycin (zithromax) (1 trial)

bovine colostrum (1 trial)

calcium (1 trial)

chlorhexidine (hibitane) (2 trials)

corn oil (1 trial)

docosahexaenoic acid (1 trial)

galactooligosaccharide (1 trial)

habekacin (1 trial)

hexachlorophene (1 trial)

levobupivacaine (chirocaine) (1 trial)

levofloxacin (levaquin) (1 trial)

loperamide (imodium) (1 trial)

methylprednisolone (medrol) (1 trial)

mupirocin (bactroban) (1 trial)

platelet rich plasma (1 trial)

rifaximin (xifaxan) (2 trials)

saccharomyces boulardii (1 trial)

soybean oil (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 2)

Brain Injuries, Traumatic (Phase 2)

Breast Neoplasms (Phase 2)

Compartment Syndromes (Phase 2)

Influenza, Human (Phase 4)

Leishmaniasis (Phase 2)

Leishmaniasis, Cutaneous (Phase 2)

Pneumonia (Phase 3)

Post-Concussion Syndrome (Phase 2)

Stress Disorders, Traumatic (Phase 2)

Syndrome (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 36
  • # of Trial APIs: 46